ResearcherAnhui Medical UniversityNo recent work listed

Kai Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6114-226X; OpenAlex author ID A5101824944. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper

Papers 1

Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition through the Wnt/β‑catenin pathway. Last author DOI 10.3892/or.2020.7641 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yajun Wei · 1 shared paper, 2020 · strength 0.13
- Paper Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition t… DOI 10.3892/or.2020.7641 ↗
Gang Wang · 1 shared paper, 2020 · strength 0.13
- Paper Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition t… DOI 10.3892/or.2020.7641 ↗
Cheng Wang · 1 shared paper, 2020 · strength 0.13
- Paper Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition t… DOI 10.3892/or.2020.7641 ↗
Jingcheng Zhang · 1 shared paper, 2020 · strength 0.13
- Paper Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial‑to‑mesenchymal transition t… DOI 10.3892/or.2020.7641 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.